Usefulness of chromogenic assays for potency assignment and recovery of plasma-derived FVIII and FIX concentrates or their recombinant long acting therapeutic equivalents with potential application in treated pediatric hemophiliac patients-Reference-Cited by-同舟云学术

Usefulness of chromogenic assays for potency assignment and recovery of plasma-derived FVIII and FIX concentrates or their recombinant long acting therapeutic equivalents with potential application in treated pediatric hemophiliac patients

Published:2018-06 Issue:3 Volume:57 Page:363-369
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Amiral Jean,Seghatchian Jerard

Publisher

Elsevier BV

Subject

Hematology

Reference28 articles.

1. Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII;Pittman;Blood,1993

2. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99;Darby;J Thromb Haemost,2004

3. Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex;Ngo;Structure,2008

4. Evaluation of three automated chromogenic FVIII kits for the diagnosis of mild discrepant haemophilia A;Rodgers;Int J Lab Hematol,2009

5. NASCOLA proficiency testing committee, laboratory assessment of factor VIII inhibitor titer: the North American specialized coagulation laboratory association experience;Peerschke;Am J Clin Pathol,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization and evaluation of a two-stage chromogenic assay procedure for measurement of emicizumab plasma levels;PLOS ONE;2022-07-14

2. Current Choices and Management of Treatment in Persons with Severe Hemophilia A without Inhibitors: A Mini-Delphi Consensus;Journal of Clinical Medicine;2022-02-02

3. An Update on Laboratory Diagnostics in Haemophilia A and B;Hämostaseologie;2022-02-01

4. Measurements of eftrenonacog alfa by 19 different combinations reagents/instrument: A single‐centre study;Haemophilia;2020-04-20

5. Recombinant blood products and therapeutic enzymes: An update;The Future of Pharmaceutical Product Development and Research;2020